Abstract

The mucosal immune system provides the first line of defense against inhaled and ingested pathogenic microbacteria and viruses. This defense system, to a large extent, is mediated by the actions of secretory IgA. In this study, we screened 140 strains of lactic acid bacteria for induction of IgA production by murine Peyer’s patch cells. We selected one strain and named it Lactobacillus plantarum AYA. We found that L. plantarum AYA-induced production of IL-6 in Peyer’s patch dendritic cells, with this production promoting IgA+ B cells to differentiate into IgA-secreting plasma cells. We also observed that oral administration of L. plantarum AYA in mice caused an increase in IgA production in the small intestine and lung. This production of IgA correlated strongly with protective ability, with the treated mice surviving longer than the control mice after lethal influenza virus infection. Our data therefore reveals a novel immunoregulatory role of the L. plantarum AYA strain which enhances mucosal IgA production and provides protection against respiratory influenza virus infection.

Highlights

  • Influenza virus (IFV) infection is a significant cause of morbidity and mortality worldwide

  • We examined the role of dendritic cells (DCs) in the IgAenhancing effect of a lactic acid bacteria (LAB) strain and investigated whether oral administration of LAB activated the immune system of the lung and protected against IFV infection

  • The present study showed that L. plantarum AYA, selected from 140 LAB strains, induced IgA production and protected against IFV infection

Read more

Summary

Introduction

Influenza virus (IFV) infection is a significant cause of morbidity and mortality worldwide. It is important to enhance local immunity to decrease the risk of IFV infection [1]. The mucosal immune system provides the first line of defense against inhaled and ingested pathogenic microbacteria and viruses. This defense system, to a large extent, is mediated by the actions of secretory IgA [2], which is the most abundantly produced Ig isotype in the body [3]. Secretary IgA antibodies in the mucosa are believed to provide primary defense against respiratory IFV infection [5], studies using IgA (2/2) mice have shown that other compensatory mechanisms may be involved in this protection [6]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call